The Use of Intralesional Clostridial Collagenase Injection Therapy for Peyronie's Disease: A Prospective, Single-Center, Non-Placebo-Controlled Study
The DOI matches its Crossref record.
Abstract
Introduction: Peyronie's disease afflicts at least 3% of sexually active men over the age of 30. Many pharmacologic therapies have been tried, but to date, no systemic or local therapy has been proven to provide predictable and lasting results. Aim: This study was designed to assess the efficacy and safety of intralesional clostridial collagenase injection therapy in a series of patients with Peyronie's disease. Methods: Twenty-five patients aged 21–75 years who were referred to a single institution with a well-defined Peyronie's disease plaque were treated with three intralesional injections of clostridial collagenase 10,000 units in a small volume (0.25 cm3 per injection) administered over 7–10 days, with a repeat treatment (i.e., three injections of collagenase 10,000 units/25 cm3 injection over 7–10 days) at 3 months. Primary efficacy measures were changes from baseline in the deviation angle and plaque size. Secondary efficacy end points were patient responses to a Peyronie's disease questionnaire and improvement according to the investigators' global evaluation of change. Main Outcome Measure: The primary efficacy measures were change in deviation angle and change in plaque size. Secondary end points were patient questionnaire responses and improvement according to the investigators’ global evaluation of change. Results: Significant decreases from baseline were achieved in the mean deviation angle at months 3 (P =0.0001) and 6 (P =0.0012), plaque width at months 3 (P =0.0052), 6 (P =0.0239), and 9 (P =0.0484), and plaque length at months 3 (P =0.0018) and 6 (P =0.0483). More than 50% of patients in this series considered themselves “very much improved” or “much improved” at all time points in the study, and the drug was generally well tolerated. Conclusion: The benefits of intralesional clostridial collagenase injections in this trial lend support to prior studies supporting its use in the management of Peyronie's disease. A double-blind, placebo-controlled study is currently under development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Gelbard, M., Goldstein, I., Hellstrom, W. J. G., McMahon, C. G., Smith, T., Tursi, J., Jones, N., Kaufman, G. J., & Carson, C. C. (2013) · Journal of Urology · doi:10.1016/j.juro.2013.01.087 · Cited by 466
The Management of Peyronie’s Disease: Evidence-based 2010 Guidelines
Ralph, D., Gonzalez-Cadavid, N., Mirone, V., Perovic, S., Sohn, M., Usta, M., & Levine, L. (2010) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2010.01850.x · Cited by 324
The Management of Peyronie's Disease: Evidence-based 2010 Guidelines
Shindel, A. (2011) · Yearbook of Urology · doi:10.1016/j.yuro.2010.12.007 · Cited by 300
Evidence-Based Management Guidelines on Peyronie's Disease
Chung, E., Ralph, D., Kagioglu, A., Garaffa, G., Shamsodini, A., Bivalacqua, T., Glina, S., Hakim, L., Sadeghi-Nejad, H., & Broderick, G. (2016) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2016.04.062 · Cited by 227
Nonsurgical management of Peyronie’s disease
Tsambarlis, P., & Levine, L. A. (2019) · Nature Reviews Urology · doi:10.1038/s41585-018-0117-7 · Cited by 64
Metadata
- Authors
- Jordan, G. H.
- Venue
- The Journal of Sexual Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-01-01
- Volume
- 5
- Issue
- 1
- Pages
- 180-187
- ISSN
- 1743-6095 (ISSN-L)
- 1743-6109
- OpenAlex
- W1604434236
- Cited by
- 125
- References
- 0
- FWCI
- 6.49
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Use of Intralesional Clostridial Collagenase Injection Therapy for Peyronie's Disease: A Prospective, Single-Center, Non-Placebo-Controlled Study. https://app.cochat.ai/papers/10.1111/j.1743-6109.2007.00651.x
- The paper
- Jordan, G. H. (2008). The Use of Intralesional Clostridial Collagenase Injection Therapy for Peyronie's Disease: A Prospective, Single-Center, Non-Placebo-Controlled Study. The Journal of Sexual Medicine. https://doi.org/10.1111/j.1743-6109.2007.00651.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.